KSQ Therapeutics IPO

KSQ Therapeutics is the developer of a genome-scale precision functional genomics platform, called CRISPRomics, designed to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.

Register for Details

For more details on financing and valuation for KSQ Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is KSQ Therapeutics's ticker symbol?

KSQ Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is KSQ Therapeutics's stock price?

The stock price for KSQ Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

KSQ Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
12/1/2021 Series D $596.57MM $XXX.XX $XXX.XX
9/28/2018 Series C $412.51MM $XXX.XX $XXX.XX
10/2/2017 Series B $145.02MM $XXX.XX $XXX.XX
3/1/2017 Series A $39.32MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about KSQ Therapeutics

Forge green plus iconForge green minus icon

What is KSQ Therapeutics funding to date?

KSQ Therapeutics has raised $257.46MM with the following series:
$39.32MM for Series A, $145.02MM for Series B, $412.51MM for Series C, $596.57MM for Series D, $39.32MM for Series A, $145.02MM for Series B, $412.51MM for Series C, $596.57MM for Series D.
Forge green plus iconForge green minus icon

When was KSQ Therapeutics founded?

KSQ Therapeutics was founded in 2015.
Forge green plus iconForge green minus icon

Can you invest in KSQ Therapeutics?

KSQ Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell KSQ Therapeutics share pre-IPO?

If you own KSQ Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is KSQ Therapeutics a publicly traded company?

KSQ Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like KSQ Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector